Design and Identification of a Novel Antiviral Affinity Peptide against Fowl Adenovirus Serotype 4 (FAdV-4) by Targeting Fiber2 Protein
Viruses · 23.03.2023 · 15 (4) · 821
DOI: 10.3390/v15040821 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 23.03.2023. Verfasst von Xiao Chen und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Northwest A&F University, Xianyang 712100, China. Hauptthemen laut MEDLINE: Adenoviridae Infections, Poultry Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Henan Academy of Agricultural Sciences.
Abstract (Originalsprache)
Outbreaks of hydropericardium hepatitis syndrome caused by fowl adenovirus serotype 4 (FAdV-4) with a novel genotype have been reported in China since 2015, with significant economic losses to the poultry industry. Fiber2 is one of the important structural proteins on FAdV-4 virions. In this study, the C-terminal knob domain of the FAdV-4 Fiber2 protein was expressed and purified, and its trimer structure (PDB ID: 7W83) was determined for the first time. A series of affinity peptides targeting the knob domain of the Fiber2 protein were designed and synthesized on the basis of the crystal structure using computer virtual screening technology. A total of eight peptides were screened using an immunoperoxidase monolayer assay and RT-qPCR, and they exhibited strong binding affinities to the knob domain of the FAdV-4 Fiber2 protein in a surface plasmon resonance assay. Treatment with peptide number 15 (P15; WWHEKE) at different concentrations (10, 25, and 50 μM) significantly reduced the expression level of the Fiber2 protein and the viral titer during FAdV-4 infection. P15 was found to be an optimal peptide with antiviral activity against FAdV-4 in vitro with no cytotoxic effect on LMH cells up to 200 μM. This study led to the identification of a class of affinity peptides designed using computer virtual screening technology that targeted the knob domain of the FAdV-4 Fiber2 protein and may be developed as a novel potential and effective antiviral strategy in the prevention and control of FAdV-4.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Veterinary Medicine, Northwest A&F University, Xianyang 712100, China.
- Henan Provincial Key Laboratory of Animal Immunology, Henan Academy of Agricultural Sciences, Zhengzhou 450002, China.
- Institute of Animal Science and Veterinary Medicine, Shanghai Academy of Agricultural Sciences, Shanghai 201106, China.
- College of Life Science, Henan Agricultural University, Zhengzhou 450002, China.
- Jiangsu Co-Innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou 225009, China.
ORCID-Profile: Fusheng Si
Förderung
- National Natural Science Foundation of China
- Henan Academy of Agricultural Sciences
Zitieren
APA
Chen, X., Wei, Q., Si, F., Wang, F., Lu, Q., Guo, Z., Chai, Y., Zhu, R., Xing, G., Jin, Q., & Zhang, G. (2023). Design and Identification of a Novel Antiviral Affinity Peptide against Fowl Adenovirus Serotype 4 (FAdV-4) by Targeting Fiber2 Protein. Viruses, 15(4), 821. https://doi.org/10.3390/v15040821
Vancouver
Chen X, Wei Q, Si F, Wang F, Lu Q, Guo Z, et al. Design and Identification of a Novel Antiviral Affinity Peptide against Fowl Adenovirus Serotype 4 (FAdV-4) by Targeting Fiber2 Protein. Viruses. 2023;15(4):821. doi:10.3390/v15040821
BibTeX
@article{Chen2023,
author = {Chen, Xiao and Wei, Qiang and Si, Fusheng and Wang, Fangyu and Lu, Qingxia and Guo, Zhenhua and Chai, Yongxiao and Zhu, Rongfang and Xing, Guangxu and Jin, Qianyue and Zhang, Gaiping},
title = {Design and Identification of a Novel Antiviral Affinity Peptide against Fowl Adenovirus Serotype 4 (FAdV-4) by Targeting Fiber2 Protein},
journal = {Viruses},
year = {2023},
volume = {15},
number = {4},
pages = {821},
doi = {10.3390/v15040821}
}
EUVIMED